ERBB3 and neoplasm: DB-1310 showed strong dose-dependent antitumor activity in the HER3-expressing NCI-H441 human lung cancer xenograft model and LU1542 lung cancer PDX models, demonstrating the dependence of HER3 expression on the tumor-suppressive activity of DB-1310 (Fig. 3a and b).